This inventor holds 5 USPTO granted patents and 8 published patent applications. Top assignees: Modernatx, Inc., Takeda Pharmaceutical Company Limited. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Paolo G V Martini: Innovator in mRNA Therapy
Introduction
Paolo G V Martini is a prominent inventor based in Boston, MA, known for his significant contributions to the field of mRNA therapy. With a total of three patents to his name, he has focused on developing innovative treatments for genetic disorders.
Latest Patents
Martini's latest patents include groundbreaking work on polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria (PKU). This invention relates to mRNA therapy aimed at treating hyperphenylalaninemias such as PKU. The mRNAs developed in this patent, when administered in vivo, encode human phenylalanine hydroxylase (PAH) and its functional fragments. These mRNAs are preferably encapsulated in lipid nanoparticles (LNPs) to ensure efficient delivery to cells and tissues. The therapy aims to increase and restore deficient levels of PAH expression and activity, thereby reducing the abnormal accumulation of phenylalanine in affected individuals.
Another significant patent by Martini focuses on polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders. This mRNA therapy targets ornithine transcarbamylase deficiency (OTCD). Similar to his previous work, the mRNAs in this patent encode human ornithine transcarbamylase (OTC) and its functional fragments. The encapsulation in lipid nanoparticles facilitates effective delivery, with the goal of restoring deficient OTC levels and decreasing toxic ammonia levels in patients.
Career Highlights
Throughout his career, Paolo G V Martini has worked with notable companies such as ModernaTX, Inc. and Takeda Pharmaceutical Company Limited. His work in these organizations has contributed to the advancement of mRNA technology and its applications in treating genetic disorders.
Collaborations
Martini has collaborated with esteemed colleagues, including Patrick Finn and Zhijian Zhuo, to further his research and development efforts in the field of mRNA therapy.
Conclusion
Paolo G V Martini is a key figure in the innovation of mRNA therapies, with a focus on treating genetic disorders such as phenylketonuria and urea cycle disorders. His contributions through patents and collaborations highlight the potential of mRNA technology in transforming medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile